We conducted a street-based intercept survey with 480 men reporting sex with men during June 2011 Gay Pride events in New York City. Awareness and knowledge of preexposure prophylaxis (PrEP) were limited. Many men believed that PrEP use should be encouraged and that some of their friends would use it, and were interested in using it themselves. Men who believed that PrEP should be taken only before sex were more likely to endorse it and report greater likelihood of use.
Introduction

R
esults from recent clinical trials demonstrating that oral preexposure prophylaxis (PrEP) reduced HIV acquisition risk by 75% in HIV-serodiscordant heterosexual couples, 1 62% in heterosexually active women and men, 2 49% in injecting drug users, 3 and 44% in HIV-negative men who have sex with men (MSM) 4 ushered in a new era of HIV antiretroviral drug-based prevention, even after disappointing results of several vaginal microbicide 5, 6 and vaccine 7 trials. To understand awareness of, beliefs about, and interest in using PrEP before its widespread promotion, we conducted a brief survey with a convenience sample of men attending Gay Pride events during the period that the U.S. Food and Drug Administration (FDA) was evaluating the combination of two antiviral drugs-oral emtricitabine and tenofovir disoproxil fumarate (Truvada)-for use as PrEP for HIV prevention.
Methods
Participants were recruited during June 2011 Gay Pride events in three New York City boroughs. Gay Men's Health Crisis and Columbia University's HIV Center for Clinical and Behavioral Studies staff/volunteers randomly approached attendees and asked them to participate in a brief anonymous survey. Attendees were eligible if they were male, at least 18 years old, and English speaking. Participants were given the option of being interviewed or completing the survey themselves. Seven hundred men participated in the survey, but this analysis is limited to the 480 men who reported having sex with a man in the preceding 6 months. Information about mode of survey administration is missing for 23 men; however, these men were included in analyses if they had valid data on other variables. None of the cases out of the 480 were systematically excluded.
Using chi-squared statistics, we examined factors associated with awareness of PrEP, belief that PrEP use should be encouraged, and personal interest in using PrEP.
Results
The proportion of men who had heard of PrEP was 38.8%, with significantly higher awareness among HIV-positive than HIV-negative men (81.0% vs. 34.7%), as shown in Table 1 . Race/ethnicity, perceived risk (among HIV-negative men), and survey administration mode were not related to awareness of PrEP.
Overall, the majority of men (79.4%) believed that all or most of their friends would use PrEP if it became readily available, while nearly half (45.4%) believed that gay men would stop using condoms if PrEP were available (not shown). Nearly three-fifths of men (58.4%) thought PrEP use should be encouraged, and a third (32.5%) had no opinion (Table 2 ). Race/ethnicity was associated with being in favor of encouraging PrEP use, with Latinos most likely to favor encouragement of PrEP (70.8%) and whites least likely to do so (52.3%). About half of men (50.9%) said that it was very likely that they themselves would use PrEP if it became easily available, and 14.1% were unsure ( Table 2) . Whether or not the men had heard about PrEP was not associated with the belief that use should be encouraged or with their intention to use it. Compared with other ethnic/racial groups, white men were the least likely to say that they would use PrEP (38.1%, vs. 66.7% of black men, and 72.0% of Latino men). Men who perceived themselves at high risk for HIV indicated that they would be more likely to use PrEP (81.4%) compared with men at low or no risk (46.7% and 46.5%, respectively).
Men who believed that PrEP should be taken only before sex were more likely to endorse PrEP use (76.1% vs. 12.5%) and report greater likelihood of using it themselves (68% vs. 18.7%). Men who thought that PrEP has a lot of side effects were the least likely to say that they would use it (27.8% compared with 63.3% and 63.6% of the men who thought that PrEP would have a few or no side effects, respectively). Men who did not advocate encouraging PrEP use were more likely to believe that PrEP has a lot of side effects and think that gay men would stop using condoms if PrEP became available. In addition, men who believed that PrEP offered more than 50% protection if taken as medically prescribed were significantly more likely to favor encouraging use and to have the intention to use PrEP.
Discussion
Despite more than 60% of sexually active MSM never having heard about PrEP, half reported interest in using it at a time when PrEP was being considered for approval as an HIV prevention tool. Many men thought that PrEP use should be encouraged and believed that some of their friends would use it. We found higher PrEP awareness (38.8%) among this 2011 sample of MSM compared with 21.4% of 457 MSM attendees of minority gay pride events in a 2005-2006 seven-city study, 8 but lower awareness than the 50% reported in a sample of 172 MSM at the June 2009 Seattle Gay Pride event. 9 Our study findings highlight the need for PrEP educational campaigns among MSM and the need for studies of individual, social, health system, and structural barriers to PrEP uptake. Although the study was conducted 1 year before the July 2012 FDA approval, 10 our data are relevant even if overall awareness might be expected to have increased since approval. It is important to note, however, that despite availability of PrEP and CDC interim guidance on use of PrEP for high-risk MSM, 11 uptake has been lower than anticipated. 12 Major challenges to uptake of PrEP remain, including system barriers (e.g., integrating PrEP into comprehensive HIV prevention and lack of a natural ''home'' for prescribing PrEP), provider barriers (e.g., identifying who is most likely to benefit from PrEP, lack of medical providers willing and trained to prescribe PrEP, concern about patient adherence), and user barriers (e.g., lack of awareness of PrEP for HIV prevention). These roadblocks must be addressed before we can expect widespread uptake of this new a Of the 480 men who had had sex with men in the preceding 6 months, information about mode of survey administration was missing for 23 men. Because of missing data, the total number in some categories is < 480.
b Men who preferred not to answer the question were excluded from these analyses. c Men who reported being HIV-positive were excluded from these analyses. MSM, men who have sex with men; PrEP, preexposure prophylaxis. Of the 480 men who had had sex with men in the preceding 6 months, information about mode of survey administration was missing for 23 men. Because of missing data, the total number in some categories is < 480. Men who reported being HIV positive were excluded from these analyses. n.a., not applicable.
biomedical HIV prevention technology among high-risk HIV-negative MSM.
